|
1.
|
Jones L, Watling RM, Wilkins S and Pizer
B: Nutritional support in children and young people with cancer
undergoing chemotherapy. Cochrane Database Syst Rev. 7:1–50.
2010.PubMed/NCBI
|
|
2.
|
Xue H, Sawyer MB, Wischmeyer PE and
Baracos VE: Nutrition modulation of gastrointestinal toxicity
related to cancer chemotherapy: from preclinical findings to
clinical strategy. J Parenter Enteral Nutr. 35:74–90. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Shike M: Nutrition therapy for the cancer
patient. Hematol Oncol Clin North Am. 10:221–234. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bozzetti F, Arends J, Lundholm K,
Micklewright A, Zurcher G and Muscaritoli M: ESPEN Guidelines on
parenteral nutrition: non-surgical oncology. Clin Nutr. 28:445–454.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Morss S: Enteral and parenteral nutrition
in terminally ill cancer patients: a review of the literature. Am J
Hosp Palliat Care. 23:369–377. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Muscaritoli M, Bossola R, Bellantone R and
Fanelli FR: Therapy of muscle wasting in cancer: what is the
future? Curr Opin Clin Nutr Metab Care. 7:459–466. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Simons JPFHA, Schols AM, Buurman WA and
Wouters EF: Weight loss and low body cell mass in males with lung
cancer: relationship with systemic inflammation, acute-phase
response, resting energy expenditure, and catabolic and anabolic
hormones. Clin Sci. 97:215–223. 1999. View Article : Google Scholar
|
|
8.
|
Barber MD: The pathophysiology and
treatment of cancer cachexia. Nutr Clin Pract. 17:203–209. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Tisdale MJ: Cachexia in cancer patients.
Nat Rev Cancer. 11:862–871. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Arends J: Metabolism in cancer patients.
Anticancer Res. 30:1863–1868. 2010.
|
|
11.
|
Van Cutsem E and Arends J: The causes and
consequences of cancer-associated malnutrition. Eur J Oncol Nurs.
9(Suppl. 2): 51–63. 2005.PubMed/NCBI
|
|
12.
|
Jatoi A, Daly BD, Hughes VA, Dallal GE,
Kehayias J and Roubenoff R: Do patients with nonmetastatic
non-small cell lung cancer demonstrate altered resting energy
expenditure? Ann Thorac Surg. 72:348–351. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Argilés JM, Olivan M, Busquets S and
López-Soriano FJ: Optimal management of cancer anorexia-cachexia
syndrome. Cancer Manag Res. 22:27–38. 2010.
|
|
14.
|
Nitenberg G and Raynard B: Nutritional
support of the cancer patient: issues and dilemmas. Crit Rev Oncol
Hematol. 34:137–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Drudge-Coates L: Improving management of
patients with advanced cancer. Patient Prefer Adherence. 2:415–424.
2010. View Article : Google Scholar
|
|
16.
|
Marín Caro MM, Laviano A and Pichard C:
Nutritional intervention and quality of life in adult oncology
patients. Clin Nutr. 26:289–301. 2007.PubMed/NCBI
|
|
17.
|
Ströhle A, Zänker K and Hahn A: Nutrition
in oncology: the case of micronutrients (Review). Oncol Rep.
24:815–828. 2010.PubMed/NCBI
|
|
18.
|
Marín Caro MM, Laviano A and Pichard C:
Impact of nutrition on quality of life during cancer. Curr Opin
Clin Nutr Metab Care. 10:480–487. 2007.PubMed/NCBI
|
|
19.
|
Tian J and Chen JS: Nutritional status and
quality of life of the gastric cancer patients in Changle County of
China. World J Gastroenterol. 11:1582–1586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Gupta D, Lis CG, Granick J, Grutsch JF,
Vashi PG and Lammersfeld CA: Malnutrition was associated with poor
quality of life in colorectal cancer: a retrospective analysis. J
Clin Epidemiol. 59:704–709. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ravasco P, Monteiro-Grillo I, Vidal PM and
Camilo ME: Cancer: disease and nutrition are key determinants of
patients' quality of life. Support Care Cancer. 12:246–252.
2004.
|
|
22.
|
Petruson KM, Silander EM and Hammerlid EB:
Quality of life as predictor of weight loss in patients with head
and neck cancer. Head Neck. 27:302–310. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Bower M, Jones W, Vessels B, Scoggins C
and Martin R: Role of esophageal stents in the nutrition support of
patients with esophageal malignancy. Nutr Clin Pract. 25:244–249.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Marín Caro MM, Gómez Candela C, Castillo
Rabaneda R, Lourenço Nogueira T, García Huerta M and Loria Kohen V:
[Nutritional risk evaluation and establishment of nutritional
support in oncology patients according to the protocol of the
Spanish Nutrition and Cancer Group]. Nutr Hosp. 23:458–468.
2008.
|
|
25.
|
Mudigonda T and Mudigonda P: Palliative
cancer care ethics: principles and challenges in the Indian
setting. Indian J Palliat Care. 16:107–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Maree JE and Wright SC: Palliative care: a
positive outcome for cancer patients? Curationis. 31:43–49. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Granda-Cameron C, Viola SR, Lynch MP and
Polomano RC: Measuring patient-oriented outcomes in palliative
care: functionality and quality of life. Clin J Oncol Nurs.
12:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wiseman M: The treatment of oral problems
in the palliative patient. J Can Dent Assoc. 72:453–458.
2006.PubMed/NCBI
|
|
29.
|
Koretz RL: Should patients with cancer be
offered nutritional support: Does the benefit outweigh the burden?
Eur J Gastroenterol Hepatol. 19:379–382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Arends J, Bodoky G, Bozzetti F, et al:
ESPEN Guidelines on enteral nutrition: non-surgical oncology. Clin
Nutr. 25:245–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
ASPEN Board of Directors: Clinical
Guidelines Task Force, Nutrition assessment – adults. J Parenter
Enteral Nutr. 26:9–12. 2002.
|
|
32.
|
Sax HC and Souba WW: Enteral and
parenteral feedings. Guidelines and recommendations. Med Clin North
Am. 77:863–880. 1993.PubMed/NCBI
|
|
33.
|
Hardman WE: Omega-3 FA to augment cancer
therapy. J Nutr. 132(Suppl. 11): 35082002.PubMed/NCBI
|
|
34.
|
Hardman WE: N-3 fatty acids and cancer
therapy. J Nutr. 134(Suppl. 12): 3427–3430. 2004.PubMed/NCBI
|
|
35.
|
Caughey GE, Mantzioris E, Gibson RA,
Cleland LG and James MJ: The effect on human tumor necrosis factor
alpha and interleukin 1beta production of diets enriched in or fish
oil. Am J Clin Nutr. 63:116–119. 1996.PubMed/NCBI
|
|
36.
|
Barber MD: Cancer cachexia and its
treatment with fish-oil-enriched nutritional supplementation.
Nutrition. 17:751–755. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Moses AW, Slater C, Preston T, Barber MD
and Fearon KC: Reduced total energy expenditure and physical
activity in cachexia patients with pancreatic cancer can be
modulated by an energy and protein dense oral supplement enriched
with n-3 fatty acids. Br J Cancer. 90:996–1002. 2004. View Article : Google Scholar
|
|
38.
|
Takatsuka H, Takemoto Y and Iwata N: Oral
eicosapentaenoic acid for complications of bone marrow
transplantation. Bone Marrow Transplant. 28:769–774. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Bruera E, Strasser F and Palmer JL: Effect
of fish oil on appetite and other symptoms in patients with
advanced cancer and anorexia/cachexia: a double-blind,
placebo-controlled study. J Clin Oncol. 21:129–134. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Wigmore SJ, Ross JA, Falconer JS, Plester
CE, Tisdale MJ, Carter DC and Fearon KC: The effect of
polyunsaturated fatty acids on the progress of cachexia in patients
with pancreatic cancer. Nutrition. 12(Suppl. 1): 27–30. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Bauer JD and Capra S: Nutrition
intervention improves outcomes in patients with cancer cachexia
receiving chemotherapy – a pilot study. Support Care Cancer.
213:270–274. 2005.PubMed/NCBI
|
|
42.
|
Fearon KC, von Meyenfeldt MF, Moses AG, et
al: Effect of a protein and energy dense n-3 fatty acid-enriched
oral supplement on loss of weight and lean tissue in cancer
cachexia: a randomised double blind trial. Gut. 52:1479–1486. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Read JA, Beale PJ, Volker DH, Smith N,
Childs A and Clarke SJ: Nutrition intervention using an
eicosapentaenoic acid (EPA)-containing supplement in patients with
advanced colorectal cancer. Effects on nutritional and inflammatory
status: a phase II trial. Support Care Cancer. 15:301–307. 2007.
View Article : Google Scholar
|
|
44.
|
Spencer L, Mann C, Metcalfe M, Webb M,
Pollard C and Spencer D: The effect of omega-3 FAs on tumour
angiogenesis and their therapeutic potential. Eur J Cancer.
45:2077–2086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Fritsche KL: Are omega-3 fatty acids
effective in enhancing tumoricidal cell activity? J Nutr.
135:2916–2917. 2005.
|
|
46.
|
Oudemans-van Straaten HM, Bosman RJ,
Treskes M, van der Spoel HJ and Zandstra DF: Plasma glutamine
depletion and patient outcome in acute ICU admissions. Intensive
Care Med. 27:84–90. 2001.PubMed/NCBI
|
|
47.
|
Berg A, Rooyackers O, Norberg A and
Wernerman J: Elimination kinetics of L-alanyl-L-glutamine in ICU
patients. Amino Acids. 29:221–228. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Darmaun D: Role of glutamine depletion in
severe illness. Diabetes Nutr Metab. 13:25–30. 2000.PubMed/NCBI
|
|
49.
|
Ziegler TR, Bazargan N and Galloway JR:
Glutamine enriched parenteral nutrition; saving nitrogen and saving
money? Clin Nutr. 19:375–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Novak F, Heyland DK, Avenell A, Drover JW
and Su X: Glutamine supplementation in serious illness: a
systematic review of the evidence. Crit Care Med. 30:2022–2029.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Goeters C, Wenn A, Mertes N, et al:
Parenteral L-alanyl-L-glutamine improves 6-month outcome in
critically ill patients. Crit Care Med. 30:2032–2037. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Wernerman J: Clinical use of glutamine
supplementation. J Nutr. 138:2040–2044. 2008.PubMed/NCBI
|
|
53.
|
Crowther M, Avenell A and Culligan DJ:
Systematic review and meta-analyses of studies of glutamine
supplementation in haematopoietic stem cell transplantation. Bone
Marrow Transplant. 44:413–425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Ziegler TR: Glutamine supplementation in
cancer patients receiving bone marrow transplantation and high dose
chemotherapy. J Nutr. 131:2578–2584. 2001.PubMed/NCBI
|
|
55.
|
Blijlevens NMA, Donnelly JP and De Pauw
BE: Mucosal barrier injury: biology, pathology, clinical
counterparts and consequences of intensive treatment for
haematological malignancy: an overview. Bone Marrow Transplant.
25:1269–1278. 2000. View Article : Google Scholar
|
|
56.
|
Elting LS, Cooksley C, Chambers M, Cantor
SB, Manzullo E and Rubenstein EB: The burdens of cancer therapy:
clinical and economic outcomes of chemotherapy-induced mucositis.
Cancer. 98:1531–1539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Sonis ST, Oster G, Fuchs H, et al: Oral
mucositis and the clinical and economic outcomes of hematopoietic
stem-cell transplantation. J Clin Oncol. 19:2201–2205.
2001.PubMed/NCBI
|
|
58.
|
Kuskonmaz B, Yalcin S, Kucukbayrak O, et
al: The effect of glutamine supplementation on hematopoietic stem
cell transplant outcome in children: a case-control study. Pediatr
Transplant. 12:47–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Aquino VM, Harvey AR, Garvin JH, et al: A
double-blind randomized placebo-controlled study of oral glutamine
in the prevention of mucositis in children undergoing hematopoietic
stem cell transplantation: a pediatric blood and marrow transplant
consortium study. Bone Marrow Transplant. 36:611–616. 2005.
View Article : Google Scholar
|
|
60.
|
Ziegler TR: Glutamine supplementation in
bone marrow transplantation. Br J Nutr. 87(Suppl. 1): 9–15. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Wilmore DW, Schloerb PR and Ziegler TR:
Glutamine in the support of patients following bone marrow
transplantation. Curr Opin Clin Nutr Metab Care. 2:323–327. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Arfons LM and Lazarus HM: Total parenteral
nutrition and hematopoietic stem cell transplantation: an expensive
placebo? Bone Marrow Transplant. 36:281–288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Whelan K and Schneider SM: Mechanisms,
prevention, and management of diarrhea in enteral nutrition. Curr
Opin Gastroenterol. 27:152–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Whelan K: Enteral-tube-feeding diarrhoea:
manipulating the colonic microbiota with probiotics and prebiotics.
Proc Nutr Soc. 66:299–306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
De Preter V, Hamer HM, Windey K and
Verbeke K: The impact of pre- and/or probiotics on human colonic
metabolism: does it affect human health? Mol Nutr Food Res.
55:46–57. 2011.
|
|
66.
|
Pagnini C, Corleto VD, Hoang SB, Saeed R,
Cominelli F and Delle Fave G: Commensal bacteria and ‘oncologic
surveillance’: suggestions from an experimental model. J Clin
Gastroenterol. 42:S193–S196. 2008.
|
|
67.
|
Pagnini C, Saeed R, Bamias G, Arseneau KO,
Pizarro TT and Cominelli F: Probiotics promote gut health through
stimulation of epithelial innate immunity. Proc Natl Acad Sci USA.
107:454–459. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Roberfroid M, Gibson GR, Hoyles L,
McCartney AL, Rastall R and Rowland I: Prebiotic effects: metabolic
and health benefits. Br J Nutr. 104(Suppl. 2): 1–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Santacroce L, Leone D, Valenzano A,
Luperto P, Bottalico L and Losacco T: Nutritional problems in the
surgical patients with head and neck tumours. Literature review and
personal experience. Clin Ter. 156:227–230. 2005.(In Italian).
|
|
70.
|
Huhmann MB and August DA: Nutrition
support in surgical oncology. Nutr Clin Pract. 24:520–526. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Huhmann MB and August DA: Review of
American Society for Parenteral and Enteral Nutrition (ASPEN)
clinical guidelines for nutrition support in cancer patients:
nutrition screening and assessment. Nutr Clin Pract. 23:182–188.
2008. View Article : Google Scholar
|
|
72.
|
Senesse P, Assenat E, Schneider S,
Chargari C, Magné N and Azria D: Nutritional support during
oncologic treatment of patients with gastrointestinal cancer: Who
could benefit? Cancer Treat Rev. 34:568–575. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Arends J, Zuercher G, Dossett A, Fietkau
R, Hug M and Schmid I: Non-surgical oncology – Guidelines on
arenteral nutrition. Ger Med Sci. 18:1–14. 2009.
|
|
74.
|
Pironi L, Joly F, Forbes A, et al:
Long-term follow-up of patients on home parenteral nutrition in
Europe: implications for intestinal transplantation. Gut. 60:17–25.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
75.
|
Orrevall Y, Tishelman C, Herrington MK and
Permert J: The path from oral nutrition to home parenteral
nutrition: a qualitative interview study of the experiences of
advanced cancer patients and their families. Clin Nutr.
23:1280–1287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Braunschweig C, Liang H and Sheean P:
Indications for administration of parenteral nutrition in adults.
Nutr Clin Pract. 19:255–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
77.
|
Dy SM: Enteral and parenteral nutrition in
terminally ill cancer patients: a review of the literature. Am J
Hosp Palliat Care. 23:369–377. 2006. View Article : Google Scholar : PubMed/NCBI
|
